1
|
Kroto HW, Heath JR, O’Brien SC, Curl RF
and Smalley RE: C60: Buckminsterfullerene. Nature. 318:162–163.
1985. View
Article : Google Scholar
|
2
|
Wang J, Chen C, Li B, et al: Antioxidative
function and biodistribution of
[Gd@C82(OH)22]n nanoparticles in
tumor-bearing mice. Biochem Pharmacol. 71:872–881. 2006.
|
3
|
Cagle DW, Kennel SJ, Mirzadeh S, Alford JM
and Wilson LJ: In vivo studies of fullerene-based materials using
endohedral metallofullerene radiotracers. Proc Natl Acad Sci USA.
96:5182–5187. 1999. View Article : Google Scholar : PubMed/NCBI
|
4
|
Chen C, Xing G, Wang J, et al:
Multihydroxylated [Gd@C82(OH)22]n
nanoparticles: antineoplastic activity of high efficiency and low
toxicity. Nano Lett. 5:2050–2057. 2005.
|
5
|
Anderson SA, Lee KK and Frank JA:
Gadolinium-fullerenol as a paramagnetic contrast agent for cellular
imaging. Invest Radiol. 41:332–338. 2006. View Article : Google Scholar : PubMed/NCBI
|
6
|
Mikawa M, Kato H, Okumura M, et al:
Paramagnetic water-soluble metallofullerenes having the highest
relaxivity for MRI contrast agents. Bioconjug Chem. 12:510–514.
2001. View Article : Google Scholar : PubMed/NCBI
|
7
|
Bolskar RD, Benedetto AF, Husebo LO, et
al: First soluble M@C60 derivatives provide enhanced access to
metallofullerenes and permit in vivo evaluation of
Gd@C60[C(COOH)2]10 as a MRI contrast agent. J
Am Chem Soc. 125:5471–5478. 2003. View Article : Google Scholar : PubMed/NCBI
|
8
|
Zhang B, Gu F, She C, et al: Reduction of
Akt2 inhibits migration and invasion of glioma cells. Int J Cancer.
125:585–595. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Guo H, Gu F, Li W, et al: Reduction of
protein kinase c zeta inhibits migration and invasion of human
glioblastoma cells. J Neurochem. 109:203–213. 2009. View Article : Google Scholar : PubMed/NCBI
|
10
|
Huang J, Chen K, Gong W, Dunlop NM and
Wang JM: G-protein coupled chemoattractant receptors and cancer.
Front Biosci. 13:3352–3363. 2008. View
Article : Google Scholar : PubMed/NCBI
|
11
|
Kurosaka S and Kashina A: Cell biology of
embryonic migration. Birth Defects Res C Embryo Today. 84:102–122.
2008. View Article : Google Scholar
|
12
|
Rorth P: Collective cell migration. Annu
Rev Cell Dev Biol. 25:407–429. 2009. View Article : Google Scholar
|
13
|
Etienne-Manneville S and Hall A:
Integrin-mediated activation of Cdc42 controls cell polarity in
migrating astrocytes through PKCzeta. Cell. 106:489–498. 2001.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Lefranc F, Brotchi J and Kiss R: Possible
future issues in the treatment of glioblastomas: special emphasis
on cell migration and the resistance of migrating glioblastoma
cells to apoptosis. J Clin Oncol. 23:2411–2422. 2005. View Article : Google Scholar : PubMed/NCBI
|
15
|
Wischhusen J, Schneider D, Mittelbronn M,
et al: Death receptor-mediated apoptosis in human malignant glioma
cells: modulation by the CD40/CD40L system. J Neuroimmunol.
162:28–42. 2005. View Article : Google Scholar : PubMed/NCBI
|
16
|
Li H and Nord EP: CD40/CD154 ligation
induces mononuclear cell adhesion to human renal proximal tubule
cells via increased ICAM-1 expression. Am J Physiol Renal Physiol.
289:F145–F153. 2005. View Article : Google Scholar : PubMed/NCBI
|
17
|
Sumimoto S and Mayumi M: [Role of
LFA-1/ICAM-1-dependent cell adhesion in CD40-mediated inhibition of
anti-IgM antibody-induced B-cell death]. Nippon Rinsho.
54:1779–1783. 1996.
|
18
|
Jain KK: Nanotechnology in clinical
laboratory diagnostics. Clin Chim Acta. 358:37–54. 2005. View Article : Google Scholar : PubMed/NCBI
|
19
|
Juillerat-Jeanneret L and Schmitt F:
Chemical modification of therapeutic drugs or drug vector systems
to achieve targeted therapy: looking for the grail. Med Res Rev.
27:574–590. 2007. View Article : Google Scholar : PubMed/NCBI
|
20
|
LaRocque J, Bharali DJ and Mousa SA:
Cancer detection and treatment: the role of nanomedicines. Mol
Biotechnol. 42:358–366. 2009. View Article : Google Scholar : PubMed/NCBI
|
21
|
Yin JJ, Lao F, Meng J, et al: Inhibition
of tumor growth by endohedral metallofullerenol nanoparticles
optimized as reactive oxygen species scavenger. Mol Pharmacol.
74:1132–1140. 2008. View Article : Google Scholar : PubMed/NCBI
|
22
|
Roebuck KA and Finnegan A: Regulation of
intercellular adhesion molecule-1 (CD54) gene expression. J Leukoc
Biol. 66:876–888. 1999.PubMed/NCBI
|